November 1, 2023 — Annalise.ai, a global leader in the radiology imaging sector, announced the launch of Annalise Triage, a solution tailored specifically for the U.S. market. This innovative software will transform the radiology field by empowering radiologists to efficiently triage studies and prioritize those with suspected critical findings, ultimately streamlining their workflow, and supporting faster time-to-diagnosis for urgent conditions. AI-enhanced worklist triaging has been shown to decrease both the time a radiologist needs to read a report, and the time from request until a report is available for critical cases.1
Annalise Triage boasts an impressive array of 12 FDA-cleared findings, including 5 for chest X-ray (CXR) and 7 for non-contrast head CT (CTB). Readily available for use across the United States, this comprehensive offering received the 510(k) clearance and the coveted breakthrough designation for obstructive hydrocephalus. Notably, Annalise Triage is the only radiology triage device to have received this distinction, which is exclusively granted to devices and products that fulfil specific criteria, which include enhancing the diagnosis or treatment of life-threatening or irreversibly debilitating conditions, offering breakthrough technology, presenting a significant advantage over existing alternatives, and being in the best interest of patients.2
By implementing Annalise Triage, radiologists can swiftly and accurately detect a range of critical, time-sensitive conditions from unenhanced head CT studies, including acute subdural hematoma, acute subarachnoid hemorrhage, intra-axial hemorrhage, intraventricular hemorrhage, obstructive hydrocephalus, mass effect, and vasogenic edema. Furthermore, it enables identification of pleural effusion, pneumoperitoneum, vertebral compression fracture, pneumothorax, and tension pneumothorax on chest X-rays. With this list of 12 time-sensitive and critical findings, Annalise Triage is the most comprehensive AI triage tool for CXR and non-contrast CTB available in the US.
In light of growing imaging backlogs and radiology workforce shortages, Annalise Triage is strategically positioned to address the pressing need to improve workflow efficiency in U.S. radiology. Worklist prioritization has emerged as a crucial use case for AI in radiology, and Annalise.ai is at the forefront of this transformative trend. Annalise.ai recognized the current industry challenges and expedited regulatory approvals to be one of the fastest AI providers to achieve 12 findings cleared by FDA in under 2 years.
Dr Rick Abramson, Chief Medical Officer at Annalise.ai, added: “Our advanced algorithms support radiologists by facilitating prioritization of studies with suspected critical findings, thereby optimizing radiology workflow. With its set of clearances, Annalise.ai promotes faster report turnaround times by identifying and elevating critical cases for immediate attention.”
One of Annalise's key strengths in the U.S. radiology triage market is the breadth and depth of its triage findings. Annalise Triage offers the most extensive radiology triage portfolio available in the United States for chest X-ray and un-enhanced head CT, aligning seamlessly with the company's track record of providing one of the most comprehensive diagnostic support portfolios worldwide. Annalise.ai algorithms are powered by one of the world’s largest, most diverse datasets and trained using a pool of 140+ fully qualified consulting radiologists.
Annalise.ai's commitment to innovation and its dedication to improving patient care continue to drive advancements in radiology. Annalise Triage is poised to redefine the radiology triage landscape in the United States, empowering healthcare professionals with cutting-edge technology with worklist prioritization to improve patient outcomes.
For more information: https://annalise.ai/
Find more RSNA conference coverage here
References:
March 13, 2026 
